Excessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease

Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

(2017) Sandro Altamura et al.   JOURNAL OF ALZHEIMERS DISEASE

Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis

(2017) Lee J. Martin   JOURNAL OF ALZHEIMERS DISEASE

Parkinson disease with REM sleep behavior disorder: Features,  -synuclein, and inflammation

(2015) Y. Hu et al.   NEUROLOGY

Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD

(2015) Yang Hu et al.   PLoS One

Apathy in Parkinson’s Disease: Diagnosis, Neuropsychological Correlates, Pathophysiology and Treatment

(2014) Gabriella Santangelo et al.   BEHAVIOURAL NEUROLOGY

Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study

(2014) Shu-yang Yu et al.   BMC Neurology

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil

(2013) Stéphane Thobois et al.   BRAIN

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

(2013) Orly Weinreb et al.   FREE RADICAL BIOLOGY AND MEDICINE

Apathy in Patients With Parkinson Disease as a Function of Side of Onset

(2013) Erica Harris et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Are Selective Serotonin Reuptake Inhibitors Associated With Greater Apathy in Parkinson’s Disease?

(2013) Laura B. Zahodne et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration

(2013) Wei Zhang et al.   MOLECULAR NEUROBIOLOGY

Brain iron accumulation in aging and neurodegenerative disorders

(2012) Jesper Hagemeier et al.   Expert Review of Neurotherapeutics

Apathy in Parkinson's disease: Diagnostic and etiological dilemmas

(2012) Sergio E. Starkstein   MOVEMENT DISORDERS

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

(2012) David N. Hauser et al.   NEUROBIOLOGY OF DISEASE

Clinical Correlates of Apathy in Patients Recently Diagnosed with Parkinson’s Disease: The ANIMO Study

(2012) Esther Cubo et al.   NEUROEPIDEMIOLOGY

Apathy in essential tremor, dystonia, and Parkinson's disease: A comparison with normal controls

(2011) Elan D. Louis et al.   MOVEMENT DISORDERS

Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

(2011) Julián Benito-León et al.   MOVEMENT DISORDERS

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

(2011) Timothy J. Collier et al.   NATURE REVIEWS NEUROSCIENCE

Apathy and depression in Parkinson’s disease: The Belgrade PD study report

(2011) Lj Ziropadja et al.   PARKINSONISM & RELATED DISORDERS

Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease

(2011) Sara Varanese et al.   PLoS One

The relevance of iron in the pathogenesis of Parkinson’s disease

(2010) Jeswinder Sian-Hülsmann et al.   JOURNAL OF NEUROCHEMISTRY

The effect of pramipexole on mood and motivational symptoms in parkinson's disease: A meta-analysis of placebo-controlled studies

(2009) Albert F.G. Leentjens et al.   CLINICAL THERAPEUTICS

Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders

(2009) P. Robert et al.   EUROPEAN PSYCHIATRY

Neuropsychiatric symptoms in Parkinson's disease

(2009) Dag Aarsland et al.   MOVEMENT DISORDERS

Dietary fats, cholesterol and iron as risk factors for Parkinson's disease

(2008) Karen M. Powers et al.   PARKINSONISM & RELATED DISORDERS